Advanced Accelerator Applications, a radiopharmaceutical diagnostics company developing its first therapeutic product, raised $75 million by offering 4.7 million shares at $16, within the range of $15 to $17. Advanced Accelerator Applications plans to list on the Nasdaq under the symbol AAAP. Citi and Jefferies acted as lead managers on the deal.
